arrow
M

Michael Paal

LMU University Hospital
H指数:23
被引数:1,643

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

First therapeutic drug monitoring of experimental favipiravir in Borna disease virus 1 (BoDV-1) encephalitis patients reveals significant gaps in antiviral treatment: a pilot investigation

首次实验性法匹拉韦在博尔纳病病毒1型(BoDV-1)脑炎患者中的治疗药物监测揭示抗病毒治疗存在显著差距:一项试点调查

2025-10-050
OAAI
Towards model-informed precision dosing of intravenous linezolid: a multicentre external evaluation of pharmacokinetic models in critically ill adults

面向注射用利奈唑胺模型指导的精确给药:一项针对重症成人患者药代动力学模型的多中心外部评估

2025-09-090
PRE
Model-informed identification of optimised dosing strategies for meropenem in critically ill patients receiving SLEDD: an observational study

基于模型识别的危重症患者接受SLEDD治疗时美罗培南优化给药策略:一项观察性研究

2025-04-250
OA
Reply to Gatti and Pea, Are the pharmacokinetic data of meropenem studied in CSF of a mixed population composed of patients with cerebral infections and patients with extracerebral infections really helpful for clinicians treating CNS infections?
2024-12-050
PRE
Meropenem pharmacokinetics in cerebrospinal fluid: comparing intermittent and continuous infusion strategies in critically ill patients-a prospective cohort study
2024-09-042
PRE